127 related articles for article (PubMed ID: 6384162)
21. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials of misonidazole in the United States.
Wasserman TH; Stetz J; Phillips TL
Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
[TBL] [Abstract][Full Text] [Related]
23. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916).
Komarnicky LT; Phillips TL; Martz K; Asbell S; Isaacson S; Urtasun R
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):53-8. PubMed ID: 1993631
[TBL] [Abstract][Full Text] [Related]
24. Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study.
Spanos WJ; Wasserman T; Meoz R; Sala J; Kong J; Stetz J
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1479-82. PubMed ID: 2442127
[TBL] [Abstract][Full Text] [Related]
25. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
Simpson JR; Bauer M; Wasserman TH; Perez CA; Emami B; Wiegensberg I; Zinninger M; Durbin LM
Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):861-7. PubMed ID: 3034841
[TBL] [Abstract][Full Text] [Related]
26. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
[TBL] [Abstract][Full Text] [Related]
27. Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
Simpson JR; Perez CA; Phillips TL; Concannon JP; Carella RJ
Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):303-8. PubMed ID: 7085386
[TBL] [Abstract][Full Text] [Related]
28. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
29. Neuropathy of nitroimidazole radiosensitizers: clinical and pathological description.
Wasserman TH; Nelson JS; VonGerichten D
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1725-30. PubMed ID: 6237085
[TBL] [Abstract][Full Text] [Related]
30. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508.
Coleman CN; Urtasun RC; Wasserman TH; Hancock S; Harris JW; Halsey J; Hirst VK
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1749-53. PubMed ID: 6237086
[TBL] [Abstract][Full Text] [Related]
31. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.
Fazekas J; Pajak TF; Wasserman T; Marcial V; Davis L; Kramer S; Rotman M; Stetz J
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1155-60. PubMed ID: 3301758
[TBL] [Abstract][Full Text] [Related]
32. Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.
Edwards MS; Powers SK; Baringer RA; Jewett DL; Bolger C; Phillips TL
J Neurooncol; 1983; 1(2):115-23. PubMed ID: 6678963
[TBL] [Abstract][Full Text] [Related]
33. Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
Bauer M; Leibel S; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Conner N; Pakuris E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1101-3. PubMed ID: 3528087
[TBL] [Abstract][Full Text] [Related]
34. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
[TBL] [Abstract][Full Text] [Related]
35. Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials.
Edwards MS; Gordon DG; Levin VA; Phillips TL
J Neurooncol; 1984; 2(2):91-4. PubMed ID: 6481428
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
Eifel PJ; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
[TBL] [Abstract][Full Text] [Related]
37. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
Eifel PJ; Brown DM; Lee WW; Brown JM
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
[TBL] [Abstract][Full Text] [Related]
38. The effect of prolonged high dose misonidazole on tumor response to radiation.
McNally NJ; de Ronde J; Hinchliffe M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma.
Busutti L; Breccia A; Stagni G; Gattavecchia E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1739-43. PubMed ID: 6480456
[TBL] [Abstract][Full Text] [Related]
40. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
Abratt RP; Barnes DR; Hammond JA; Sarembok LA; Tucker RD; Williams AM
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
